Zymergen

Entity > Corporation > US > Emeryville California > Zymergen

About Zymergen

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Zymergen

Company Attribute Value
Address StreetAddress: 5980 Horton St Ste 105, AddressLocality: Emeryville, AddressRegion: California, PostalCode: 94608, AddressCountry: United States
Founding Date 2013
Name Zymergen
Number Of Employees 502
Revenue $17,799,000 USD
Ticker Symbol NASDAQ: ZY
Url zymergen
Facebook facebook
Linkedin linkedin
Twitter twitter
Wikipedia wikipedia
Google google
Wikidata wikidata

Zymergen

us

Emeryville, US
19 Jun 2024

Emeryville, US
19 Jun 2024

Zymergen

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.ginkgobioworks.com › 2022/10/19 › gink...
Ginkgo Acquires Zymergen Ginkgo Bioworks
Oct 19, 2022 — Today, we're pleased to announce our completed acquisition of Zymergen. This is our largest acquisition to date!
https://en.wikipedia.org › wiki › Zymergen
Zymergen
Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design ...
https://www.forbes.com › Business › Manufacturing
The Inside Story Of How SoftBank-Backed Zymergen ...
Oct 13, 2021 — Zymergen raised $500 million when it went public in April, on top of more than $1 billion in venture funding. By August, its CEO was out and ...
https://www.fiercebiotech.com › biotech › seven-month...
7 months after biotech pivot, Zymergen is acquired by Ginkgo
Jul 25, 2022 — Ginkgo will look for “strategic alternatives” for Zymergen's drug discovery business once the $300 million sale is complete.
https://manufacturingchemist.com › where-zymergen-w...
Where Zymergen went wrong: a biomanufacturing ...
Oct 12, 2022 — It doesn't seem that Zymergen had a clear plan to manufacture their product. This is particularly alarming considering the massive scale of the ...
https://www.crunchbase.com › organization › zymergen
Zymergen - Crunchbase Company Profile & Funding
Zymergen is a biotechnology company that specializes in machine learning, big data, and artificial intelligence.
https://www.biospace.com › article › zymergen-cuts-80...
Zymergen Cuts 80 More Jobs, Parts Ways with Co-Founder
Aug 26, 2022 — In an SEC filing, Zymergen revealed it was cutting 80 more jobs and parting with Zach Serber, its co-founder and chief scientific officer.
https://www.cnbc.com › 2021/08/03 › zymergen-zy-pl...
Zymergen (ZY) plunges 68% on forecast for 'immaterial' ...
Aug 3, 2021 — Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion. The stock sank to $11.07 ...
https://agfundernews.com › brief-ginkgo-bioworks-buys...
Brief: Ginkgo Bioworks buys Zymergen for $300m
Jul 26, 2022 — Zymergen will be acquired by fellow cell manufacturing company Ginkgo Bioworks for $300m, a sharp fall from Zymergen's once $3 billion ...
https://www.prnewswire.com › news-releases › ginkgo-bi...
Ginkgo Bioworks Completes Acquisition of Zymergen
Oct 19, 2022 — Zymergen shares will no longer be traded on Nasdaq. Ginkgo Class A common stock will continue to trade on NYSE under the ticker symbol DNA.
Related Searches
Related Searches
Zymergen stock
zymergen products
Zymergen news
Knowledge Panel
Knowledge Panel

Zymergen (Biotechnology company)

Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms.

en.wikipedia.org/wiki/Zymergen
  • Parent organization : Ginkgo Bioworks
  • Date founded : 2013
  • Founders : Jed Dean; Josh Hoffman; Zach Serber
  • Headquarters : Emeryville, California, U.S
  • Traded as : Nasdaq: ZY

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194131